An in vivo study showed that SIRT4 exacerbates Ang II-induced cardiac hypertrophy by overexpressing and inhibiting MnSOD activity, providing new directions and targets for treating cardiac hypertrophy [125]. Here, SIRT4 is linked to cardiac hypertrophy.